Reslizumab deemed safe, efficacious for treatment of asthma
Healio In a recent extension study, researchers found reslizumab was safe, efficacious and improved Asthma Quality of Life scores for up to 2 years after beginning treatment, according to data recently presented at the American College of Allergy, Asthma and … |
View full post on asthma – Google News